How many insider declarations has Huang Ying filed?

Huang Ying has filed 2 public insider declarations with SEC (Form 4).

What is Huang Ying's role?

Huang Ying's reported role is not specified by the regulator across the filings.

Which companies does Huang Ying report trades for?

Huang Ying reports trades for Legend Biotech Corp.

What is Huang Ying's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 75k€.

← Executives ★ Sign in to follow

HY

Huang Ying

CEOF

·SEC (Form 4)

Legend Biotech Corp

0

申报总数

0

公司

—

▲ 买入（0 笔）

€75,025

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the detailed record of transactions filed by Huang Ying. Officer active across 1 company, notably Legend Biotech Corp. In total, 2 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €75k. Activity tracked since 25 March 2026. The latest transaction was filed on 25 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Huang Ying

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Legend Biotech Corp (US)

申报2 总计

▼

Huang Ying

Chief Executive Officer高管2026年6月25日Legend Biotech Corp

0SEC ↗

5,566 股Ordinary SharesSEC:0001967360-26-000006:0

▼

Huang Ying

Chief Executive Officer高管2026年3月25日Legend Biotech Corp

US$87,13930SEC ↗

9,936 股@ US$8.77100.0% 占其流量Ordinary SharesSEC:0001967360-26-000004:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

HY

Huang Ying

CEOF

·SEC (Form 4)

Legend Biotech Corp

0

申报总数

0

公司

—

▲ 买入（0 笔）

€75,025

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the detailed record of transactions filed by Huang Ying. Officer active across 1 company, notably Legend Biotech Corp. In total, 2 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €75k. Activity tracked since 25 March 2026. The latest transaction was filed on 25 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.